These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30714880)

  • 1. Randomized pilot trial of Web-based cognitive-behavioral therapy adapted for use in office-based buprenorphine maintenance.
    Shi JM; Henry SP; Dwy SL; Orazietti SA; Carroll KM
    Subst Abus; 2019; 40(2):132-135. PubMed ID: 30714880
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine.
    Fiellin DA; Barry DT; Sullivan LE; Cutter CJ; Moore BA; O'Connor PG; Schottenfeld RS
    Am J Med; 2013 Jan; 126(1):74.e11-7. PubMed ID: 23260506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial.
    Schramm ZA; Leroux BG; Radick AC; Ventura AS; Klein JW; Samet JH; Saxon AJ; Kim TW; Tsui JI
    Addict Sci Clin Pract; 2020 Jul; 15(1):30. PubMed ID: 32736660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of behavioral treatment conditions in buprenorphine maintenance.
    Ling W; Hillhouse M; Ang A; Jenkins J; Fahey J
    Addiction; 2013 Oct; 108(10):1788-98. PubMed ID: 23734858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine.
    Stein MD; Herman DS; Moitra E; Hecht J; Lopez R; Anderson BJ; Brown RA
    Drug Alcohol Depend; 2015 Feb; 147():243-50. PubMed ID: 25510307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the feasibility, acceptability, and preliminary efficacy of cognitive-behavioral therapy for opioid use disorder and chronic pain.
    Barry DT; Beitel M; Cutter CJ; Fiellin DA; Kerns RD; Moore BA; Oberleitner L; Madden LM; Liong C; Ginn J; Schottenfeld RS
    Drug Alcohol Depend; 2019 Jan; 194():460-467. PubMed ID: 30508769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-assisted delivery of cognitive-behavioral therapy: efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone.
    Carroll KM; Kiluk BD; Nich C; Gordon MA; Portnoy GA; Marino DR; Ball SA
    Am J Psychiatry; 2014 Apr; 171(4):436-44. PubMed ID: 24577287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment.
    Moore BA; Fiellin DA; Cutter CJ; Buono FD; Barry DT; Fiellin LE; O'Connor PG; Schottenfeld RS
    J Subst Abuse Treat; 2016 Dec; 71():54-57. PubMed ID: 27776678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding an Internet-delivered treatment to an efficacious treatment package for opioid dependence.
    Christensen DR; Landes RD; Jackson L; Marsch LA; Mancino MJ; Chopra MP; Bickel WK
    J Consult Clin Psychol; 2014 Dec; 82(6):964-72. PubMed ID: 25090043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial.
    Marsden J; Stillwell G; James K; Shearer J; Byford S; Hellier J; Kelleher M; Kelly J; Murphy C; Mitcheson L
    Lancet Psychiatry; 2019 May; 6(5):391-402. PubMed ID: 30952568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trial.
    Gunderson EW; Wang XQ; Fiellin DA; Bryan B; Levin FR
    Addict Behav; 2010 May; 35(5):537-40. PubMed ID: 20106601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Implementing Shared Medical Appointments (SMAs) for Office-Based Opioid Treatment With Buprenorphine: A Pilot Study.
    Suzuki J; Zinser J; Klaiber B; Hannon M; Grassi H; Spinosa M; Ramirez A; Issa M; Chin Feman SP
    Subst Abus; 2015; 36(2):166-9. PubMed ID: 25738320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.
    Sigmon SC; C Meyer A; Hruska B; Ochalek T; Rose G; Badger GJ; Brooklyn JR; Heil SH; Higgins ST; Moore BA; Schwartz RP
    Addict Behav; 2015 Dec; 51():136-42. PubMed ID: 26256469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of mindful body awareness training as an adjunct to office-based medication treatment of opioid use disorder.
    Price CJ; Merrill JO; McCarty RL; Pike KC; Tsui JI
    J Subst Abuse Treat; 2020 Jan; 108():123-128. PubMed ID: 31174929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of buprenorphine and psychosocial treatment outcomes in psychosocial and medical settings.
    Presnall NJ; Wolf DAPS; Brown DS; Beeler-Stinn S; Grucza RA
    J Subst Abuse Treat; 2019 Sep; 104():135-143. PubMed ID: 31370977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers.
    Sigmon SC; Dunn KE; Saulsgiver K; Patrick ME; Badger GJ; Heil SH; Brooklyn JR; Higgins ST
    JAMA Psychiatry; 2013 Dec; 70(12):1347-54. PubMed ID: 24153411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study protocol of the ESUB-MG cluster randomized trial: a pragmatic trial assessing the implementation of urine drug screening in general practice for buprenorphine maintained patients.
    ESUB-MG Study Group
    BMC Fam Pract; 2016 Mar; 17():24. PubMed ID: 26931763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Office-Based Addiction Treatment Retention and Mortality Among People Experiencing Homelessness.
    Fine DR; Lewis E; Weinstock K; Wright J; Gaeta JM; Baggett TP
    JAMA Netw Open; 2021 Mar; 4(3):e210477. PubMed ID: 33662132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive-behavioral therapy and buprenorphine for opioid use disorder: A systematic review and meta-analysis of randomized controlled trials.
    Gregory VL; Ellis RJB
    Am J Drug Alcohol Abuse; 2020 Sep; 46(5):520-530. PubMed ID: 32960649
    [No Abstract]   [Full Text] [Related]  

  • 20. Office-Based Buprenorphine Treatment: Identifying Factors That Promote Retention in Opioid-Dependent Patients.
    Noe SR; Keller T
    J Addict Nurs; 2020; 31(1):23-29. PubMed ID: 32132421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.